This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Nanjing Heron Pharmaceutical Science and Technology Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Inventor Profile: Xingran Chen
Introduction
Xingran Chen is an innovative inventor based in Nanjing, China. He is currently associated with Nanjing Heron Pharmaceutical Science and Technology Co., Ltd. Despite having no granted patents to his name, Chen is actively involved in the development of pharmaceutical compositions that aim to improve patient outcomes.
Latest Patent Applications
Xingran Chen's notable patent application is titled "KETOROLACO DERIVATIVE, PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR AND USE THEREOF." This application describes a ketorolaco derivative that exhibits a better half-life and stability, along with favorable pharmacokinetic properties. The invention addresses common issues associated with traditional ketorolaco preparations, such as frequent administration, gastrointestinal side effects, and poor patient compliance.
Conclusion
Xingran Chen's contributions to pharmaceutical science reflect his commitment to enhancing drug efficacy and safety. His work continues to pave the way for advancements in medication development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile